PARENOGEN Trademark

Trademark Overview


On Thursday, September 10, 1953, a trademark application was filed for PARENOGEN with the United States Patent and Trademark Office. The USPTO has given the PARENOGEN trademark a serial number of 71652993. The federal status of this trademark filing is EXPIRED as of Monday, February 27, 1995. This trademark is owned by CUTTER LABORATORIES. The PARENOGEN trademark is filed in the Pharmaceutical Products category with the following description:

MEDICINAL PREPARATION-NAMELY, A STERILE BLOOD FRACTION, USEFUL IN THE TREATMENT OF FIBRINOGEN DEFICIENCIES AND FOR OTHER MEDICAL USES OF FIBRINOGEN
parenogen

General Information


Serial Number71652993
Word MarkPARENOGEN
Filing DateThursday, September 10, 1953
Status900 - EXPIRED
Status DateMonday, February 27, 1995
Registration Number0590286
Registration DateTuesday, May 25, 1954
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMEDICINAL PREPARATION-NAMELY, A STERILE BLOOD FRACTION, USEFUL IN THE TREATMENT OF FIBRINOGEN DEFICIENCIES AND FOR OTHER MEDICAL USES OF FIBRINOGEN

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes018
Class Status Code9 - Expired
Class Status DateMonday, February 27, 1995
Primary Code018
First Use Anywhere DateMonday, February 4, 1952
First Use In Commerce DateThursday, April 2, 1953

Trademark Owner History


Party NameCUTTER LABORATORIES
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBERKELEY, CA

Trademark Events


Event DateEvent Description
Monday, February 27, 1995EXPIRED SEC. 9
Saturday, May 25, 1974REGISTERED AND RENEWED (FIRST RENEWAL - 20 YRS)